stem cell transplantation
Showing 9976 - 10000 of >10,000
NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)
Recruiting
- Non-small Cell Lung Cancer Metastatic
- Stereotactic body radiation therapy (SBRT)
- Temporary Stopping
-
Stockholm, Solna, SwedenKarolinska University Hospital
Nov 9, 2023
Multinational Haemapheresis Vigilance Study
Active, not recruiting
- Blood Donation With Hemapheresis
- blood donation
- (no location specified)
Jul 21, 2021
HEAD & NECK Cancer Trial in New York (ribavirin)
Active, not recruiting
- HEAD & NECK Cancer
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 11, 2023
Autism Spectrum Disorder Trial in Wuhan (Fecal microbiota transplantation, Vancomycin)
Recruiting
- Autism Spectrum Disorder
- Fecal microbiota transplantation
- Vancomycin
-
Wuhan, Hubei, China
- +1 more
Jul 1, 2021
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Houston (AL101, Therapeutic Conventional Surgery)
Recruiting
- Adenoid Cystic Carcinoma
- Metastatic Adenoid Cystic Carcinoma
- AL101
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Cabozantinib Post First-line Immuno-oncology Checkpoint
Completed
- Advanced Renal Cell Carcinoma (aRCC)
-
Glasgow, United Kingdom
- +8 more
Jun 30, 2022
Sarcoidosis With Myocarditis, Sarcoidosis, Healthy Trial in Iowa City (cell free DNA)
Recruiting
- Sarcoidosis With Myocarditis
- +3 more
- cell free DNA
-
Iowa City, Iowa
- +1 more
May 16, 2022
Pulmonary Tumor, Advanced Cancer, Locally Advanced Cancer Trial in Shanghai (Surgery)
Recruiting
- Pulmonary Neoplasm
- +2 more
- Surgery
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai JiaoTong University School of Medicine
Dec 15, 2022
Nervous System Diseases, Cardiovascular and Cerebrovascular Diseases Trial in Jinan
Recruiting
- Nervous System Diseases
- Cardiovascular and Cerebrovascular Diseases
-
Jinan, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Oct 19, 2023
NSCLC Trial in Houston (Amivantamab, Tepotinib)
Not yet recruiting
- Non-small Cell Lung Cancer
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Head Neck Cancer Trial in Madison (NKTR-214, anti-PD-1 therapy, Palliative Radiation)
Active, not recruiting
- Head and Neck Cancer
- NKTR-214
- +2 more
-
Madison, WisconsinUniversity of Wisconsin
May 9, 2022
Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell
Recruiting
- Gastric Adenocarcinoma
- +2 more
- CT041 autologous CAR T-cell injection
- Physician's Choice(Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody)
-
Hefei, Anhui, China
- +9 more
Feb 13, 2022
Blastic Plasmacytoid Dendritic Cell Neoplasm in Korean
Completed
- Blastic Plasmacytoid Dendritic Cell Neoplasm
-
Seoul, Gang Nam, Korea, Republic ofSamsung medical center
Sep 1, 2020
Cardiomyopathy Following Stem Cell Transplantation
Completed
- Cardiomyopathy
-
Bethesda, Maryland
- +1 more
Jun 30, 2017
Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)
Recruiting
- Colon Cancer
- Chimeric antigen receptor T cell preparation targeting GCC
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
May 16, 2023
Kidney Cancer Trial in Houston (Axitinib)
Active, not recruiting
- Kidney Cancer
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 2, 2022
Rehabilitation Trial in Konya (High Induction Magnetic Field Therapy, Conservative Treatment)
Recruiting
- Rehabilitation
- High Induction Magnetic Field Therapy
- Conservative Treatment
-
Konya, Karatay, TurkeyKTO Karatay University
Nov 3, 2023
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Afatinib Dimaleate
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Cancer Disease Trial in Shenzhen (bi-4SCAR GD2/CD70 T cells)
Recruiting
- Cancer Disease
- bi-4SCAR GD2/CD70 T cells
-
Shenzhen, Guangdong, ChinaShenzhen Geno-immune Medical Institute
Jun 25, 2022
Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Copanlisib
- +2 more
-
Los Angeles, California
- +4 more
Jul 19, 2022